🇺🇸 FDA
Company

Axsome

Axsome Therapeutics

AXSM pharma USA

Quick answer

Axsome is a pharma company (AXSM) headquartered in NEW YORK, NY, USA with 24 tracked pipeline programs.

Pipeline (24)

project

AXS-02

Osteoarthritis, Knee

Phase 3 · small_molecule · active

1 trials project

AXS-02 (oral zoledronate)

Complex Regional Pain Syndrome

Phase 3 · small_molecule · active

1 trials project

AXS-05

Agitation in Patients With Dementia of the Alzheimer's Type

Phase 3 · small_molecule · completed

3 trials project

AXS-05

Depression

Phase 3 · small_molecule · completed

1 trials project

AXS-05

Treatment Resistant Major Depressive Disorder

Phase 3 · small_molecule · completed

1 trials project

AXS-05 (dextromethorphan and bupropion) oral tablets

Major Depressive Disorder

Phase 3 · small_molecule · completed

1 trials project

AXS-05 (dextromethorphan-bupropion)

Agitation in Patients With Dementia of the Alzheimer's Type

Phase 3 · small_molecule · completed

2 trials project

AXS-07

Migraine

Phase 3 · small_molecule · completed

1 trials project

AXS-07 (MoSEIC meloxicam and rizatriptan)

Migraine

Phase 3 · small_molecule · completed

2 trials project

AXS-07 (meloxicam-rizatriptan)

Migraine

Phase 3 · small_molecule · completed

1 trials project

AXS-12 (Reboxetine)

Narcolepsy

Phase 3 · small_molecule · completed

3 trials project

AXS-14 (Esreboxetine)

Fibromyalgia

Phase 3 · small_molecule · active

1 trials project

Solriamfetol 150 MG

Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Phase 3 · small_molecule · active

1 trials project

Solriamfetol 150 mg

Excessive Sleepiness

Phase 3 · small_molecule · active

1 trials project

Solriamfetol 150 mg

ADHD

Phase 3 · small_molecule · completed

1 trials project

Solriamfetol 150 mg

Binge-Eating Disorder

Phase 3 · small_molecule · active

1 trials project

Solriamfetol 300 mg

Major Depressive Disorder

Phase 3 · small_molecule · completed

1 trials project

Solriamfetol 75mg, 150 mg, or 300 mg

Binge-Eating Disorder

Phase 3 · small_molecule · active

1 trials project

AXS-05

Treatment Resistant Depression

Phase 2 · small_molecule · completed

1 trials project

AXS-05

Smoking Cessation

Phase 2 · small_molecule · completed

1 trials project

AXS-05 (dextromethorphan-bupropion)

Treatment Resistant Depression

Phase 2 · small_molecule · terminated

1 trials project

Dextromethorphan-Bupropion

Major Depressive Disorder (MDD)

Phase 2 · small_molecule · active

1 trials project

Solriamfetol

Multiple Sclerosis

Phase 2 · small_molecule · active

1 trials project

Solriamfetol 150 mg Oral Tablet

Narcolepsy

Phase 1 · small_molecule · completed

1 trials

Drugs (3)

drug

bupropion hydrochloride

BUPROPION HYDROCHLORIDE

 drug

meloxicam

MELOXICAM

 drug

solriamfetol hydrochloride

SUNOSI

Patents (8)

patent

US 12390419

Formulations of (R)-2-amino-3-phenylpropyl carbamate

Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12384743

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12370196

Pharmaceutical compositions comprising meloxicam

Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12357640

Pharmaceutical compositions comprising meloxicam

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12357697

Pharmaceutical compositions comprising bupropion and cysteine

Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318362

Methods of providing solriamfetol therapy to subjects with impaired renal functi

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12268693

Pharmaceutical compositions comprising a tolfenamic acid

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12263145

Methods of administering solriamfetol to lactating women

Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)